Korsana Biosciences, Inc.
KRSA Healthcare Biotechnology
In the quarter to June 2026, revenue fell 43.2%, EPS fell 272.7% and free cash flow fell 184.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow KRSA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
3.24 | 3.23 | 7.57 | 13.38 | 53.96 | 54.40 | 94.90 | — | — | — |
Receivables |
1.00 | 0.56 | — | 0.10 | 0.10 | 0.13 | 1.47 | — | — | — |
Other current assets |
0.01 | 0.02 | 0.01 | 0.54 | 0.47 | 3.16 | 2.86 | 0.01 | 0.01 | 0.28 |
Total current assets |
4.64 | 4.23 | 8.02 | 14.82 | 55.46 | 58.50 | 101.20 | 0.88 | 1.26 | 0.28 |
Property, Plant, Equpment (Net) |
— | — | — | — | 0.07 | 6.87 | 11.61 | 6.50 | 4.13 | 3.60 |
Long-Term Investments |
5.35 | 5.35 | 5.35 | — | — | 3.84 | 4.99 | — | — | — |
Long-term assets (Other) |
— | — | — | 2.04 | 2.41 | 6.61 | 5.53 | 0.03 | 0.08 | — |
Total non-current assets |
5.35 | 5.35 | 5.35 | 3.26 | 3.87 | 56.88 | 85.28 | 6.52 | 4.21 | — |
Total Assets |
9.99 | 9.58 | 13.37 | 18.08 | 59.33 | 115.38 | 186.48 | 7.40 | 5.47 | 3.88 |
Notes Payable |
— | — | — | — | — | 3.51 | — | — | — | — |
Accounts Payable |
0.51 | 0.39 | 1.20 | 2.97 | 1.83 | 1.44 | 3.31 | 2.78 | 1.80 | 1.41 |
Accrued Expenses |
0.39 | 0.34 | 0.89 | 4.66 | 9.26 | 8.72 | 11.52 | 15.07 | 12.24 | — |
Other current liabilities |
— | — | — | — | — | — | — | — | — | 9.23 |
Total current liabilities |
0.90 | 0.73 | 2.09 | 7.63 | 11.09 | 16.95 | 18.25 | 17.85 | 14.04 | 10.64 |
Total non-current liabilities |
— | — | — | — | — | 38.93 | 70.50 | — | — | — |
Total liabilities |
0.90 | 0.73 | 2.09 | 7.63 | 11.09 | 55.89 | 88.75 | 17.85 | 14.04 | 10.64 |
Additional Paid In Capital |
280.11 | 276.34 | 275.72 | 269.63 | 263.35 | 222.95 | 183.38 | — | — | — |
Retained Earnings |
(271.02) | (267.49) | (264.42) | (259.15) | (215.08) | (163.43) | (85.63) | — | — | — |
Shareholders Equity (Other) |
— | — | — | — | — | — | — | (10.44) | — | — |
Common Equity (Total) |
9.09 | 8.85 | 11.29 | 10.45 | 48.25 | 59.49 | 97.73 | (10.44) | (8.57) | (6.76) |
Shareholders Equity (Total) |
9.09 | 8.85 | 11.29 | 10.45 | 48.25 | 59.49 | 97.73 | (10.44) | (8.57) | (6.76) |
Shareholders Equity and Liabilities (Total) |
9.99 | 9.58 | 13.37 | 18.08 | 59.33 | 115.38 | 186.48 | 7.40 | 5.47 | — |
Shares (Common) |
0.55 | 0.36 | 0.35 | 0.31 | 0.31 | 0.24 | 0.20 | 27.40 | — | — |
Shareholders Equity (Tangible) |
9.09 | 8.85 | 11.29 | 10.45 | 48.25 | 59.49 | 97.73 | (10.44) | (8.57) | — |
Net Debt |
(3.24) | (3.23) | (7.57) | (13.38) | (53.96) | (54.39) | (94.89) | — | — | — |
Total Debt |
— | — | — | — | — | 45.74 | 73.92 | — | — | — |